PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS

Journal of Lipid Research

Volumn 46, Issue 11, 2005, Pages 2488-2496

  Kessen, Ursula A ^a   Schaloske, Ralph H ^a   Stephens, Daren L ^a   Lucas, Karin Killermann ^a   Dennis, Edward A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Antisense inhibitor; Arachidonic acid; Eicosanoid; Lipopolysaccharide; Macrophage; Prostaglandin E 2

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; ARACHIDONIC ACID; CYCLOOXYGENASE 2; ICOSANOID; LIPOPOLYSACCHARIDE; MESSENGER RNA; PHOSPHOLIPASE A2; PHOSPHOLIPASE A2 INHIBITOR; PROSTAGLANDIN E2; PYRROPHENONE; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; COMPLEMENTARY DNA; ENZYME INHIBITOR; INDOLE DERIVATIVE; LIPID; LY 311727; PHOSPHOLIPASE A; PHOSPHOLIPASE A2 V, TRIMERESURUS; PHOSPHOLIPASE A2-V, TRIMERESURUS; PYRROLIDINE DERIVATIVE; RNA;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STIMULATION; CELL STRAIN P388D1; CONTROLLED STUDY; CYTOSOL; ENZYME INHIBITION; ENZYME RELEASE; LONG TERM EXPOSURE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; ANIMAL; CHEMISTRY; CULTURE MEDIUM; GENETIC TRANSFECTION; IMMUNOBLOTTING; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME; UPREGULATION;

ANIMALS; ARACHIDONIC ACID; CELL LINE; CULTURE MEDIA; CYCLOOXYGENASE 2; DINOPROSTONE; DNA, COMPLEMENTARY; EICOSANOIDS; ENZYME INHIBITORS; IMMUNOBLOTTING; INDOLES; LIPIDS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHOLIPASES A; PYRROLIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 27444434282     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M500325-JLR200     Document Type: Article

References (34)

1. 2. J. Biol. Chem. 269: 13057-13060.
2. 2 reveals a novel topology and catalytic mechanism. Cell. 97: 349-360.
3. 2+-dependent translocation domain with homology to PKC and GAP. Cell. 65: 1043-1051.
4. 2. J. Biol. Chem. 266: 14850-14853.
5. 2s. J. Biol. Chem. 274: 12263-12268.
6. 2-dependent induction of cyclooxygenase-2 in macrophages. J. Biol. Chem. 274: 25967-25970.
7. 2 by methyl arachidonyl fluorophosphonate. Biochim. Biophys. Acta. 1302: 55-60.
8. 2: structure-function studies with vesicle, micelle, and membrane assays. Biochim. Biophys. Acta. 1420: 45-56.
9. De Petrocellis, L., D. Melck, N. Ueda, S. Maurelli, Y. Kurahashi, S. Yamamoto, G. Marino, and V. Di Marzo. 1997. Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. Biochem. Biophys. Res. Commun. 231: 82-88.
10. Deutsch, D. G., R. Omeir, G. Arreaza, D. Salehani, G. D. Prestwich, Z. Huang, and A. Howlett. 1997. Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. Biochem. Pharmacol. 53: 255-260.
11. Kell, P. J., M. H. Creer, K. N. Crown, K. Wirsig, and J. McHowat. 2003. Inhibition of platelet-activating factor (PAF) acetylhydrolase by methyl arachidonyl fluorophosphonate potentiates PAF synthesis in thrombin-stimulated human coronary artery endothelial cells. J. Pharmacol. Exp. Ther. 307: 1163-1170.
12. Ates, M., M. Hamza, K. Seidel, C. E. Kotalla, C. Ledent, and H. Guhring. 2003. Intrathecally applied flurbiprofen produces an endocannabinoid-dependent antinociception in the rat formalin test. Eur. J. Neurosci. 17: 597-604.
13. Fernando, S., and R. Pertwee. 1997. Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonist. Br. J. Pharmacol. 121: 1716-1720.
14. 2-alpha. J. Biol. Chem. 279: 25024-25038.
15. Koller, E., W. A. Gaarde, and B. P. Monia. 2000. Elucidating cell signaling mechanisms using antisense technology. Trends Pharmacol. Sci. 21: 142-148.
16. Urban, E., and C. R. Noe. 2003. Structural modifications of antisense oligonucleotides. Farmaco. 58: 243-258.
17. Baker, B. F., T. P. Conclon, E. Koller, R. A. McKay, A. M. Siwkowski, T. A. Vickers, and B. P. Monia. 2001. Discovery and analysis of antisense oligonucleotide activity in cell culture. Methods. 23: 191-198.
18. Kurreck, J. 2003. Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem. 270: 1628-1644.
19. 2. Part 2: synthesis of potent and crystallized 4-triphenylmethylthio derivative 'pyrrophenone.' Bioorg. Med. Chem. J. Lett. 11: 587-590.
20. 2 alpha, pyrrophenone. Biochem. J. 363: 727-735.
21. Schaloske, R. H., J. W. Provins, U. A. Kessen, and E. A. Dennis. 2005. Molecular characterization of the lipopolysaccharide/platelet activating factor- and zymosan-induced pathways leading to prostaglandin production in P388D, macrophages. Biochim. Biophys. Acta. 1687: 64-75.
22. 2 types in biological samples by employing group-specific assays in the presence of inhibitors. Prostaglandins Other Lipid Mediat. 77: 235-248.
23. Levin, A. A. 1999. A review of the issues in the pharmacokinetics and toxicology of phosphorothioate antisense oligonucleotides. Biochim. Biophys. Acta. 1489: 69-84.
24. Brown, D., S. Rang, S. Gryaznov, L. DeDionisio, O. Heidenreich, S. Sullivan, X. Xu, and M. Nerenberg. 1994. Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem. 269: 26801-26805.
25. 2 in zymosan-induced eicosanoid generation and vascular permeability revealed by targeted gene disruption. J. Biol. Chem. 279:16488-16494.
26. 2 regulation. J. Biol. Chem. 275: 20146-20156.
27. 2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J. Biol. Chem. 275: 3179-3191.
28. 2. J. Biol. Chem. 277: 48535-48549.
29. 2 and distal prostaglandin synthase 1. J. Biol. Chem. 271: 186-191.
30. 2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J. Biol. Chem. 274: 3103-3115.
31. 2 and their receptors and binding proteins. Biochim. Biophys. Acta. 1488: 59-70.
32. 2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation. Arterioscler. Thromb. Vasc. Biol. 24: 762-767.
33. 2. J. Biol. Chem. 277: 5849-5857.
34. 2 internalization and degradation. J. Biol. Chem. 276: 11126-11134.